
Effect of anemia on hepatotoxicity of HAART in HIV patients in Benin city
Author(s) -
Rose Ugiagbe,
Emeka Eze
Publication year - 2011
Publication title -
nigerian medical journal/nigerian medical journal
Language(s) - English
Resource type - Journals
eISSN - 2229-774X
pISSN - 0300-1652
DOI - 10.4103/0300-1652.86127
Subject(s) - medicine , anemia , adverse effect , gastroenterology , antiretroviral therapy , human immunodeficiency virus (hiv) , hepatitis , pediatrics , immunology , viral load
Hepatotoxicity is a relevant adverse effect of highly active antiretroviral Treatment owing to its frequency, and it can cause interruption of therapy, hepatitis, and death. There is dearth of information on hepatotoxicity arising from highly active antiretroviral therapy (HAART) in anemic patients. Anemia is the most common symptom in human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome. We studied the effect of anemia on hepatotoxicity in HIV patients who were about to start HAART, attending clinic, or in the medical wards.